Osada, Hirotaka
Aichi Cancer Center Research Institute
4 papers on CoChat
Most cited papers
- Verified
NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
Yamaguchi, T., Yanagisawa, K., Sugiyama, R., Hosono, Y., Shimada, Y., Arima, C., Kato, S., Tomida, S., Suzuki, M., Osada, H., et al. (2012) · Cancer Cell
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 249
- Verified
TGF-β Synergizes with Defects in the Hippo Pathway to Stimulate Human Malignant Mesothelioma Growth
Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., et al. (2012) · Journal of Experimental Medicine
Hippo pathway signaling and YAP/TAZOccupational and environmental lung diseases
Cited by 224
- Verified
RhoB is frequently downregulated in non‐small‐cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line
Sato, N., Fukui, T., Taniguchi, T., Yokoyama, T., Kondo, M., Nagasaka, T., Goto, Y., Gao, W., Ueda, Y., Yokoi, K., et al. (2007) · International Journal of Cancer
Lung Cancer Research StudiesMechanisms of cancer metastasis
Cited by 56
- Verified
Convergent Signaling in the Regulation of Connective Tissue Growth Factor in Malignant Mesothelioma: TGFβ Signaling and Defects in the Hippo Signaling Cascade
Fujii, M., Nakanishi, H., Toyoda, T., Tanaka, I., Kondo, Y., Osada, H., & Sekido, Y. (2012) · Cell Cycle
Hippo pathway signaling and YAP/TAZTGF-β signaling in diseases
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free